Granite Investment Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Granite Investment Partners’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-66,514	Closed	-$3.7M	–	285
2020 Q2	$3.7M	Buy	66,514 +2,021	+3%	+$86.5K	0.18%	127
2020 Q1	$1.91M	Sell	64,493 -47,526	-42%	-$1.61M	0.12%	161
2019 Q4	$4.05M	Buy	112,019 +40,786	+57%	+$1.25M	0.19%	121
2019 Q3	$1.94M	Buy	71,233 +714	+1%	+$18.5K	0.1%	163
2019 Q2	$1.7M	Buy	70,519 +13,300	+23%	+$337K	0.09%	169
2019 Q1	$1.51M	Buy	57,219 +10,401	+22%	+$246K	0.09%	165
2018 Q4	$915K	Buy	+46,818	New	+$918K	0.07%	178

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Granite Investment Partners's HZNP Position: Q3 2020 in Review

Granite Investment Partners sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2020, closing a stake of 66,514 shares — an estimated $3.7M sold.

Granite Investment Partners first reported a position in HZNP in Q4 2018 and held it in 7 quarters. The position peaked at $4.05M in Q4 2019. 433 funds tracked by Wall St. Rank hold HZNP as of Q3 2020.

Granite Investment Partners reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2020 after selling out during the quarter.
Granite Investment Partners sold 66,514 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2020, an estimated $3.7M.
Granite Investment Partners first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2018 and held it in 7 quarters.
Granite Investment Partners's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $4.05M in Q4 2019.
433 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2020.

Based on Granite Investment Partners's 13F filing for Q3 2020, filed 6 Nov 2020.